A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan ® in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension | Zendy

Arun Narayanaswamy | Zendy; Aditya Neog | Zendy; Mani Baskaran | Zendy; Ronnie George | Zendy; Vijaya Lingam | Zendy; Chetan Desai | Zendy; Viraj Rajadhyaksha | Zendy

Open Access

A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan ® in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension

Author(s) -

Arun Narayanaswamy,

Aditya Neog,

Mani Baskaran,

Ronnie George,

Vijaya Lingam,

Chetan Desai,

Viraj Rajadhyaksha

Publication year - 2007

Publication title -

indian journal of ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 51

eISSN - 1998-3689

pISSN - 0301-4738

DOI - 10.4103/0301-4738.30707

Subject(s) - medicine , latanoprost , tolerability , ocular hypertension , intraocular pressure , open angle glaucoma , glaucoma , adverse effect , ophthalmology , crossover study , randomized controlled trial , placebo , alternative medicine , pathology

To compare the efficacy and tolerability of Xalatan with generic latanoprost (Latoprost) in subjects with primary open angle glaucoma (POAG) or ocular hypertension (OH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research